AMPLE trial demonstrates equivalent safety profiles and efficacy between abatacept and adalimumab in RA Data from AMPLE presented at EULAR 2013, the Annual Congress of the European Little league Against Rheumatism, demonstrate comparable efficacy and similar basic safety profiles between subcutaneous abatacept and adalimumab www.bluepill.net . AMPLE, the first two-year head-to-head biologics trial, was made up of 646 biologic-na-ve patients with active rheumatoid arthritis equally randomised to either ABA or ADA, with a stable dosage of methotrexate .
Beginning in 1998, AMN began acquiring or creating others and/or brands, first in the nursing field and later on in doctor and allied. From one brand in 1985 to the first choice in the health care staffing industry today, AMN right now operates five nursing brands ; two physician brands ; and three allied brands . ‘Our 25 years of quality-focused and innovative service delivery is a primary reflection of our team users,’ Nowakowski said. ‘Our success and brand reputation depends on our team members and managers who are passionate about delivering the highest quality service to our clients and consistently improving our approach to the business.